|December 8, 2000||Myriad Genetics Acquires Exclusive Rights to Cancer Drug in Phase II Human Clinical Trials|
|December 8, 2000||Encore Pharmaceuticals Lincenses Lead Cancer Compound to Myriad Genetics|
|April 10, 2000||Encore Updates Clinical Development of E-7869 in Cancer|
|April 17, 2000||Encore Reports on Clinical Development Progress with Their Lead Drug Candidate E-7869|
|April 15, 1999||Encore Pharmaceuticals Begins Phase IIa Clinical Trial in Prostate Cancer Patients|
Farmacia cialis online trattamento medico degli uomini.
Home | Corporate Profile | Intellectual Properties | Press Releases | Scientific References | Contact Us